Gohealth Inc

GOCO remains in a Stage 4 decline with persistent lower highs and lower lows under declining EMAs. Relief rallies into the 9/20/50EMA and 50DMA quickly reject, and volume clusters on down moves confirm supply dominance. Short-term trend is down, with no exhaustion visible, making selling now into any bounce the optimal execution posture.

• ↑Launched GoHealth Protect, offering guaranteed-acceptance life insurance for diversification.
• ↑Q4’24 revenue $389M (+41% YoY) and adjusted EBITDA $118M (+107% YoY).
• ↓Q3’25 revenue fell 10% due to intentional Medicare Advantage pullback.